Aisling Capital LLC This is a life science investment firm that focuses on investing on companies that manufacture and sell innovative healthcare products, services, and technologies. The firm submitted its SEC 13F Filings on November 14, 2014, for the financial quarter ended September 30, 2014. The filings show that Versartis Inc (NASDAQ:VSAR), Transenterix Inc (NYSEMKT:TRXC),…